发明名称 Hydroxy pipecolate hydroxamic acid derivatives
摘要 A compound of the formula wherein R1, R2 R3, R4 R5, R6, R7, R8, R9 and Ar are as defined above, useful in the treatment of a condition selected from the group consisting of arthritis, cancer, and other diseases characterized by matrix metalloproteinase or mammalian reprolysin activity. In addition, the compounds of the present invention may be used in combination therapy with standard non-steroidal anti-inflammatory drugs (NSAID'S), COX-2 inhibitors and analgesics, and in combination with cytotoxic drugs such as adriamycin, daunomycin, cis-platinum, etoposide, taxol, taxotere and other alkaloids, such as vincristine, in the treatment of cancer.
申请公布号 US2003008901(A1) 申请公布日期 2003.01.09
申请号 US20010008943 申请日期 2001.12.03
申请人 MCCLURE KIM F.;NOE MARK C.;LETAVIC MICHAEL A..;CHUPAK LOUIS S. 发明人 MCCLURE KIM F.;NOE MARK C.;LETAVIC MICHAEL A..;CHUPAK LOUIS S.
分类号 C07D211/60;A61K;A61K31/435;A61K31/443;A61K31/445;A61K31/4523;A61K31/4525;A61K31/454;A61P1/02;A61P1/04;A61P3/10;A61P9/08;A61P11/00;A61P11/06;A61P17/00;A61P19/02;A61P19/10;A61P25/00;A61P25/28;A61P27/02;A61P31/04;A61P31/18;A61P35/00;A61P37/06;A61P37/08;A61P43/00;C07D;C07D211/00;C07D211/66;C07D211/96;C07D401/12;C07D405/12;C07D409/12;C07D413/12;(IPC1-7):A61K31/452;C07D211/06 主分类号 C07D211/60
代理机构 代理人
主权项
地址